Mutares Sets Sights on US Market with Successful Capital Raise

Mutares completes €26.4M private placement, oversubscribed by international investors. Funds will fuel North American growth, targeting Chemicals & Automotive deals.

Fresh capital is now flowing into Mutares SE & Co. KGaA following the settlement of a private placement to institutional investors. The company raised approximately €26.4 million from the sale of 1.08 million new shares at €24.50 each, marking the first tranche of a broader capital increase that could generate gross proceeds of up to €105 million. The offering was met with robust demand, with the order book nearly three times oversubscribed by more than 30 long-term oriented investors.

A significant majority of this demand, over 60 percent, originated from international investors, primarily based in the United States and Great Britain. This strong foreign appetite underscores confidence in the investment company's strategic direction. The funds are earmarked for a decisive push into North America, with roughly 80 percent allocated to this expansion.

The US strategy involves establishing a second office alongside its existing Chicago base to manage a pipeline of potential transactions with a cumulative sales volume of approximately €4.8 billion. Management is particularly targeting the Chemicals & Materials and Automotive segments, anticipating that higher exit multiples in the US market can drive substantial value creation.

This growth initiative is supported by ongoing operational momentum. The company recently confirmed the signing of an agreement to acquire two supplier operations from Magna, which will bolster its Amaneos and HiLo platforms. This follows a first quarter that saw three acquisitions and six signed exit transactions, with a second quarter plan for three more signings and four closings.

For existing shareholders, the rights offering period is now open, running until April 21, 2026. Shareholders can trade their subscription rights on the Frankfurt Stock Exchange, with a deadline of April 16 to sell them on the secondary market if they choose not to exercise. The subscription price is set at €24.50, with a ratio of five existing shares granting the right to purchase one new share. With the current share price hovering around €25.60, the incentive to subscribe is somewhat limited as the offer price sits just below the market level.

A key date for investors is April 28, when the new shares from this rights issue will be delivered. Coinciding with this, the company will publish its full annual report for 2025. Preliminary figures are promising, showing group sales rose to €6.5 billion and holding net income climbed to €130.4 million. Looking further ahead, Mutares forecasts 2026 revenues between €7.9 and €9.1 billion, with holding profit projected in a range of €165 to €200 million.

The long-term ambition remains aggressive. The company aims to grow its holding net result by an average of 25 percent annually through 2030. The remaining 20 percent of the capital raise proceeds will be used to strengthen the balance sheet as Mutares executes this transatlantic expansion plan.